FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210412466> ?p ?o ?g. }

• W4210412466 abstract "Abstract Background Upper limb impairment affects activity and participation in children with unilateral cerebral palsy (UCP). Pressure garment therapy (PGT) using compressive dynamic Lycra ® garments is an innovative intervention proposed for the management of cerebral palsy consequences. The PROPENSIX study aims to evaluate the efficacy of a therapy using a Lycra ® sleeve as compared to a placebo sleeve to improve bi-manual performance measured by the Assisting Hand Assessment (AHA) in children with unilateral cerebral palsy. Methods The PROPENSIX trial is a multicenter, prospective, placebo-controlled, double-blinded, randomized study. One hundred children with UCP, aged from 5 to 10, are randomly assigned as soon as they are recruited in a 1:1 ratio to perform usual daily activities, especially activities involving bimanual performances, with Lycra ® sleeve or placebo sleeve during 6 months. The primary endpoint is the change in bimanual performance from inclusion to 6 months, evaluated by AHA. The secondary endpoints evaluate changes from inclusion to 6 months in other dimensions of the International Classification of Functioning (ICF), upper limb movement capacity assessed by Quality of Upper Extremity Skill Test (QUEST), and health-related quality of life evaluated by Pediatric Quality of Life Inventory 3.0 Cerebral Palsy Module (PedsQLTM 3.0 CP Module) and in body structures and functions domain assessed by neuro-orthopedic examination and somatosensory evoked potentials (SEP). Discussion The PROPENSIX study is the largest randomized controlled trial (RCT) aiming to evaluate the efficacy of a PGT using compressive dynamic Lycra ® sleeve in UCP. Enhancement of children’s bimanual performance at the end of the 6 months wear of the Lycra ® sleeve should improve evidence regarding this type of treatment and expand discussion about their recommendation in clinical practice. Data from secondary outcomes assessments should bring interesting arguments to discuss the Lycra ® sleeve action on mobility, tonus, and sensory impairments in children with unilateral cerebral palsy. Trial registration ClinicalTrials.gov NCT02086214 . Retrospectively registered on March 13, 2014 Trial status Study start data: December 2012. Recruitment status: completed. Primary completion date: April 2021. Estimated study completion date: December 2022. Protocol version 10 (date: February 2018)." @default.
• W4210412466 created "2022-02-08" @default.
• W4210412466 creator A5005205127 @default.
• W4210412466 creator A5029384183 @default.
• W4210412466 creator A5030813603 @default.
• W4210412466 creator A5031872603 @default.
• W4210412466 creator A5047942803 @default.
• W4210412466 creator A5048627230 @default.
• W4210412466 creator A5057941998 @default.
• W4210412466 creator A5059286261 @default.
• W4210412466 creator A5064622434 @default.
• W4210412466 creator A5078960211 @default.
• W4210412466 creator A5085054011 @default.
• W4210412466 date "2022-02-05" @default.
• W4210412466 modified "2023-10-01" @default.
• W4210412466 title "PROPENSIX: pressure garment therapy using compressive dynamic Lycra® sleeve to improve bi-manual performance in unilateral cerebral palsy: a multicenter randomized controlled trial protocol" @default.
• W4210412466 cites W1561666912 @default.
• W4210412466 cites W1979913012 @default.
• W4210412466 cites W1980170967 @default.
• W4210412466 cites W1984005579 @default.
• W4210412466 cites W1995323771 @default.
• W4210412466 cites W2000033588 @default.
• W4210412466 cites W2000957179 @default.
• W4210412466 cites W2002552382 @default.
• W4210412466 cites W2006730366 @default.
• W4210412466 cites W2007239126 @default.
• W4210412466 cites W2007878166 @default.
• W4210412466 cites W2011735071 @default.
• W4210412466 cites W2022167001 @default.
• W4210412466 cites W2044078610 @default.
• W4210412466 cites W2065122687 @default.
• W4210412466 cites W2065974896 @default.
• W4210412466 cites W2080789138 @default.
• W4210412466 cites W2081310355 @default.
• W4210412466 cites W2081791101 @default.
• W4210412466 cites W2083704861 @default.
• W4210412466 cites W2097079955 @default.
• W4210412466 cites W2103589991 @default.
• W4210412466 cites W2110611426 @default.
• W4210412466 cites W2111717629 @default.
• W4210412466 cites W2112139841 @default.
• W4210412466 cites W2115098571 @default.
• W4210412466 cites W2115161372 @default.
• W4210412466 cites W2116322597 @default.
• W4210412466 cites W2118502261 @default.
• W4210412466 cites W2119204965 @default.
• W4210412466 cites W2125430832 @default.
• W4210412466 cites W2127120587 @default.
• W4210412466 cites W2127833072 @default.
• W4210412466 cites W2135302270 @default.
• W4210412466 cites W2148301646 @default.
• W4210412466 cites W2152425345 @default.
• W4210412466 cites W2153132838 @default.
• W4210412466 cites W2153914530 @default.
• W4210412466 cites W2156480857 @default.
• W4210412466 cites W2160619669 @default.
• W4210412466 cites W2166223138 @default.
• W4210412466 cites W2168448906 @default.
• W4210412466 cites W2173230460 @default.
• W4210412466 cites W2200901411 @default.
• W4210412466 cites W2332578461 @default.
• W4210412466 cites W2348528624 @default.
• W4210412466 cites W2734148911 @default.
• W4210412466 cites W2736255997 @default.
• W4210412466 cites W2900224079 @default.
• W4210412466 cites W4238925772 @default.
• W4210412466 cites W4242819749 @default.
• W4210412466 doi "https://doi.org/10.1186/s13063-022-06041-1" @default.
• W4210412466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35123557" @default.
• W4210412466 hasPublicationYear "2022" @default.
• W4210412466 type Work @default.
• W4210412466 citedByCount "1" @default.
• W4210412466 countsByYear W42104124662023 @default.
• W4210412466 crossrefType "journal-article" @default.
• W4210412466 hasAuthorship W4210412466A5005205127 @default.
• W4210412466 hasAuthorship W4210412466A5029384183 @default.
• W4210412466 hasAuthorship W4210412466A5030813603 @default.
• W4210412466 hasAuthorship W4210412466A5031872603 @default.
• W4210412466 hasAuthorship W4210412466A5047942803 @default.
• W4210412466 hasAuthorship W4210412466A5048627230 @default.
• W4210412466 hasAuthorship W4210412466A5057941998 @default.
• W4210412466 hasAuthorship W4210412466A5059286261 @default.
• W4210412466 hasAuthorship W4210412466A5064622434 @default.
• W4210412466 hasAuthorship W4210412466A5078960211 @default.
• W4210412466 hasAuthorship W4210412466A5085054011 @default.
• W4210412466 hasBestOaLocation W42104124661 @default.
• W4210412466 hasConcept C141071460 @default.
• W4210412466 hasConcept C142724271 @default.
• W4210412466 hasConcept C159110408 @default.
• W4210412466 hasConcept C168563851 @default.
• W4210412466 hasConcept C1862650 @default.
• W4210412466 hasConcept C203092338 @default.
• W4210412466 hasConcept C204787440 @default.
• W4210412466 hasConcept C27081682 @default.
• W4210412466 hasConcept C2779421357 @default.
• W4210412466 hasConcept C2779951463 @default.
• W4210412466 hasConcept C71924100 @default.
• W4210412466 hasConcept C99508421 @default.
• W4210412466 hasConceptScore W4210412466C141071460 @default.
• W4210412466 hasConceptScore W4210412466C142724271 @default.

• next